Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$42.27 USD
+2.56 (6.45%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $42.20 -0.07 (-0.17%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | 0.26 |
EPS Last Quarter | 0.32 |
Last EPS Surprise | 39.13% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.10 |
Next Year | 1.57 |
EPS (TTM) | 1.13 |
P/E (F1) | 35.97 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 171.04M | 176.93M | 658.57M | 721.72M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 177.84M | 180.10M | 668.55M | 766.92M |
Low Estimate | 165.70M | 170.90M | 647.20M | 646.67M |
Year ago Sales | 123.60M | 135.41M | 482.38M | 658.57M |
Year over Year Growth Est. | 38.38% | 30.66% | 36.53% | 9.59% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.26 | 0.29 | 1.10 | 1.57 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | 0.20 | 0.26 | 1.03 | 1.33 |
High Estimate | 0.34 | 0.35 | 1.26 | 1.76 |
Low Estimate | 0.20 | 0.25 | 1.03 | 1.33 |
Year ago EPS | 0.28 | 0.28 | 0.94 | 1.10 |
Year over Year Growth Est. | -7.14% | 3.57% | 17.02% | 42.18% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 5 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.26 | 0.29 | 1.10 | 1.57 |
7 Days Ago | 0.26 | 0.29 | 1.10 | 1.57 |
30 Days Ago | 0.26 | 0.29 | 1.10 | 1.57 |
60 Days Ago | 0.23 | 0.27 | 0.95 | 1.49 |
90 Days Ago | 0.23 | 0.27 | 0.95 | 1.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.26 | 0.29 | 1.10 | 1.57 |
Zacks Consensus Estimate | 0.26 | 0.29 | 1.10 | 1.57 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.32 | 0.25 | 0.28 | 0.28 | NA |
Estimate | 0.23 | 0.21 | 0.25 | 0.22 | NA |
Difference | 0.09 | 0.04 | 0.03 | 0.06 | 0.06 |
Surprise | 39.13% | 19.05% | 12.00% | 27.27% | 24.36% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more